Skip to main content
. 2022 Jun 15;10:902298. doi: 10.3389/fcell.2022.902298

TABLE 1.

Univariate and multivariate Cox regression analysis of risk score and other clinical features in the TCGA/CGGA/GEO cohorts.

Variables Univariate analysis Multivariate analysis
HR (95% CI) p-value HR (95% CI) p-value
TCGA cohort
Risk score 14.595 (9.487–22.454) 3.66E-30 10.829 (5.154–22.754) 3.21E-10
Age 3.119 (2.096–4.640) 5.19E-09 2.235 (1.431–3.490) 4.04E-04
IDH mutation 6.307 (4.325–9.198) 4.10E-18 0.657 (0.326–1.323) 2.39E-01
Grade 3.312 (2.227–4.926) 4.36E-10 2.183 (1.415–3.367) 4.15E-04
1p/19q codel 0.400 (0.250–0.641) 2.95E-05 0.615 (0.364–1.040) 6.97E-02
GEO cohort
Risk score 3.689 (2.145–6.344) 4.37E-05 6.620 (1.102–39.775) 3.88E-02
Age 1.101 (0.743–1.632) 6.30E-01 1.028 (0.692–1.527) 8.90E-01
IDH1 mutation 0.254 (0.166–0.389) 1.49E-08 0.471 (0.227–0.976) 4.28E-02
Grade 1.961 (1.288–2.986) 2.57E-03 1.049 (0.627–1.754) 8.56E-01
CGGA cohort
Risk Score 5.296 (3.523–7.961) 1.26E-13 3.641 (1.977–6.705) 3.36E-05
Age 1.154 (0.776–1.718) 4.78E-01 1.492 (0.947–2.350) 8.42E-02
IDH mutation 3.168 (2.082–4.820) 3.30E-07 0.831 (0.653–2.218) 5.53E-01
Grade 2.506 (1.625–3.863) 1.38E-05 3.125 (1.886–5.178) 9.70E-06
1p/19q codel 0.202 (0.107–0.381) 3.96E-09 0.321 (0.159–0.650) 1.57E-03

P-values marked in bold were considered significant statistically(p < 0.05).